The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Claforan Powder for Solution for Injection 1g

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/037/003

Main Information

Trade NameClaforan Powder for Solution for Injection 1g
Active SubstancesCefotaxime sodium
Dosage FormPowder for solution for injection
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/037/003

Group Information

ATC CodeJ01DD Third-generation cephalosporins
J01DD01 cefotaxime


License statusAuthorised
Licence Issued13/05/1981
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back